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Introduction
The aryl hydrocarbon receptor (AhR) has 
established roles in toxicology and phase I 
drug metabolism (Tijet et al.  2006). 
Moreover, because mice with whole-body 
AhR deficiency exhibit organ abnormalities 
(Abbott et al. 1999; Fernandez-Salguero et al. 
1997; Harstad et al. 2006; Lahvis et al. 2005; 
Vasquez et al. 2003), endogenous ligand acti-
vation of this receptor has been implicated in 
the control of proliferation and/or differentia-
tion of various cell types. Several studies have 
demonstrated marked sequestration of xeno-
biotic ligands of AhR, including lipophilic 
coplanar polychlorinated biphenyls (PCBs) 
(Brown and Lawton 1984; Fukano and 
Doguchi 1977; McFarland and Clarke 1989), 
in adipose tissue. Rather than serve as an 
inert storage reservoir for PCBs (Bourez et al. 
2012, 2013), adipocyte AhR activation by 
coplanar PCB AhR ligands promoted adipose 
inflammation (Arsenescu et al. 2008; Kim 
et al. 2012). In addition, administration of 
coplanar PCBs to lean mice impaired glucose 
and insulin tolerance, and these effects were 
abolished by an AhR antagonist (Baker 
et al. 2013b). Impaired glucose homeo stasis 
in mice exposed to coplanar PCBs was 
associated with an adipose-specific increase 
in expression of tumor necrosis factor-α 
(TNF-α), a cytokine linked to impairment 
of insulin-stimulated glucose uptake. These 
results suggest that in addition to serving as a 
storage reservoir, adipocytes respond to PCBs 
to promote inflammation and negatively 
influence glucose homeostasis.
Due to bioaccumulation in adipose lipids, 
the total body burden of PCBs is increased in 
obese rodents and humans (Kim et al. 2011; 
Myre and Imbeault 2014; Pelletier et al. 
2003). Interestingly, in contrast to lean mice, 
in which adminis tration of PCB-77 impaired 
glucose and insulin tolerance (Baker et al. 
2013b), mice that were obese from consump-
tion of a high-fat (HF) diet showed no effect 
of PCB-77 on glucose or insulin tolerance. 
In contrast, during periods of weight loss, 
PCB concentrations in adipose tissue decrease 
and serum concentrations of PCBs increase 
(Chevrier et al. 2000; Irigaray et al. 2006). 
Moreover, when obese mice adminis tered 
PCB-77 were subjected to weight loss, they 
exhibited impairments in glucose and insulin 
tolerance that blunted the beneficial effects 
of weight loss (Baker et al. 2013b). One 
possible explanation for this observation is 
that hydrophobic PCBs are released upon 
lipolysis within adipocytes during weight loss 
to act systemically, or to alternately interact 
with the cytosolic AhR within adipocytes.
In this study, we hypothesized that 
coplanar PCBs promote insulin resistance 
and impair glucose homeo stasis through 
adipocyte-specific AhR activation. To test 
this hypothesis, we generated mice with 
adipocyte AhR deficiency (AhRAdQ). Because 
coplanar PCBs impair glucose homeo stasis 
in lean mice, we defined the role of adipocyte 
AhR on PCB-induced impairment of glucose 
and insulin tolerance in mice fed a low-fat 
(LF) diet. Moreover, because the bioaccu-
mulation of lipophilic PCBs is altered with 
obesity and upon weight loss, we examined 
the role of adipocyte AhR during the 
develop ment of HF diet–induced obesity and 
during weight loss in obese mice previously 
exposed to PCB-77.
Materials and Methods
Chemicals. 3,3´,4,4´-Tetrachlorobiphenyl 
(PCB-77) was purchased from AccuStandard 
Inc. (New Haven, CT).
Animal treatments and sample collection. 
All experiments met the approval of the 
Animal Care and Use Committee of the 
University of Kentucky. Animals used in 
this study were treated humanely and with 
regard for the alleviation of suffering. Mice 
were maintained in individually ventilated 
cages (Sealsafe Plus Mouse IVC Green Line; 
*These authors contributed equally to this work.
Address correspondence to L.A. Cassis, Department 
of Pharmacology and Nutritional Sciences, Room 
521b, Wethington Building, 900 S. Limestone, 
University of Kentucky, Lexington, KY 40536-0200 
USA. Telephone: (859) 218-1400. E-mail: lcassis@
uky.edu
Supplemental Material is available online (http://
dx.doi.org/10.1289/ehp.1408594).
This research was supported by National Institute 
of Environmental Health Sciences, National 
Institutes of Health (NIH), grant P42 ES 007380 
(L.A.C.) and through research cores supported 
by NIH grant P20 GM103527-06 (L.A.C.); and 
trainee support (N.A.B.) was provided by NIH T32 
3048107792 (L.A.C.). 
The authors declare they have no actual or potential 
competing financial interests.
Received: 23 April 2014; Accepted: 2 March 
2015; Advance Publication: 3 March 2015; Final 
Publication: 1 October 2015.
Effects of Adipocyte Aryl Hydrocarbon Receptor Deficiency on PCB-Induced 
Disruption of Glucose Homeostasis in Lean and Obese Mice
Nicki A. Baker,1* Robin Shoemaker,1* Victoria English,1 Nika Larian,1 Manjula Sunkara,2 Andrew J. Morris,2 
Mary Walker,3 Frederique Yiannikouris,1 and Lisa A. Cassis1
1Department of Pharmacology and Nutritional Sciences, and 2Division of Cardiovascular Medicine, University of Kentucky, Lexington, 
Kentucky, USA; 3Department of Pharmaceutical Sciences, University of New Mexico, Albuquerque, New Mexico, USA 
Background: Coplanar polychlorinated biphenyls (PCBs) promote adipocyte inflammation and 
impair glucose homeostasis in lean mice. The diabetes-promoting effects of lipophilic PCBs have 
been observed only during weight loss in obese mice. The molecular mechanisms linking PCB 
exposures to impaired glucose metabolism are unclear.
oBjectives: In this study we tested the hypothesis that coplanar PCBs act at adipocyte aryl 
hydrocarbon receptors (AhRs) to promote adipose inflammation and impair glucose homeostasis in 
lean mice and in obese mice during weight loss.
Methods and results: PCB-77 administration impaired glucose and insulin tolerance in LF 
(low fat diet)–fed control (AhRfl/fl) mice but not in adipocyte AhR–deficient mice (AhRAdQ). 
Unexpectedly, AhRAdQ mice exhibited increased fat mass when fed a standard LF or high fat (HF) 
diet. In mice fed a HF diet, both genotypes became obese, but AhRAdQ mice administered vehicle 
(VEH) exhibited increased body weight, adipose mass, adipose inflammation, and impaired 
glucose tolerance compared with AhRfl/fl controls. Impairment of glucose homeostasis in response 
to PCB-77 was not observed in obese mice of either genotype. However, upon weight loss, AhRfl/fl 
mice administered PCB-77 exhibited increased abundance of adipose tumor necrosis factor-α 
(TNF-α) mRNA and impaired glucose homeostasis compared with those administered VEH. 
In contrast, PCB-77 had no effect on TNF-α or glucose homeostasis in AhRAdQ mice exhibiting 
weight loss.
conclusions: Our results demonstrate that adipocyte AhR mediates PCB-induced adipose 
inflammation and impairment of glucose homeostasis in mice. Moreover, deficiency of AhR in 
adipocytes augmented the development of obesity, indicating that endogenous ligand(s) for AhR 
regulate adipose homeostasis.
citation: Baker NA, Shoemaker R, English V, Larian N, Sunkara M, Morris AJ, Walker M, 
Yiannikouris F, Cassis LA. 2015. Effects of adipocyte aryl hydrocarbon receptor deficiency on 
PCB-induced disruption of glucose homeostasis in lean and obese mice. Environ Health Perspect 
123:944–950; http://dx.doi.org/10.1289/ehp.1408594
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Tecniplast) with an ad libitum automated 
water system (Endstrom), with aspen wood 
chip bedding (Harlan Teklad Sani-Chips; 
Harlan Laboratories) and cotton nesting 
squares (Neslet; Ancare) containing a small 
amount of shredded paper (Enviro-Dri; 
Shepherd Specialty Papers) for enrich-
ment. Conditions included a light/dark 
cycle of 14 hr/10 hr, a temperature of 70°C 
(± 2°C), and humidity ranging from 30 to 
70%. AhR-floxed (AhRfl/fl) mice with loxP 
sites flanking exon 2 were a generous gift 
of M. Walker (University of New Mexico) 
(Agbor et al. 2011). Female AhRfl/fl mice were 
bred to hemi zygous transgenic male Cre mice 
under control of an adiponectin/promoter/
enhancer [B6;FVB-Tg(Adipoq-cre)1Evdr/J; 
The Jackson Laboratory]. Male AhRfl/fl litter-
mate controls and AhRAdQ mice were used in 
all experiments. There were no overt differ-
ences in health or appearance between geno-
types at the start of the study. Mice of each 
genotype were randomly assigned to study 
groups for each specific experiment. A total 
of 86 mice were used in these experiments, 
of which n = 37 were AhRfl/fl, and n = 49 
were AhRAdQ. Of the total 86 mice, n = 27 
were adminis tered vehicle (VEH; tocopherol-
stripped safflower oil), and n = 28 mice were 
administered PCB-77.
In experiments confirming the efficiency 
and specificity of adipocyte AhR deletion, 
male mice of each genotype (n = 5/genotype) 
were fed standard mouse diet (Harlan 
Teklad 2918 Global Rodent Diet, irradi-
atedU; Harlan Laboratories) ad libitum from 
weaning to 2 months of age.
In experiments examining lean mice, male 
mice (2 months of age) of each genotype were 
adminis tered VEH or PCB-77 [50 mg/kg; 
by oral gavage at approximately 1000 hours 
given once in week 1 and once in week 2; 
n = 3–8 mice/group (Baker et al. 2013b)] and 
fed an LF diet (10% kcal as fat, D12450B; 
Research Diets) ad libitum. Mice in each 
group were examined 48 hr after the last 
administered dose (week 2).
For experiments on obese mice, mice 
(2 months of age) were fed an HF diet 
(60% kcal as fat, D12492; Research Diets) 
ad libitum for 12 weeks to promote the 
development of obesity. Mice of each geno
type were adminis tered VEH or PCB-77 
(50 mg/kg; by oral gavage at approximately 
1000 hours given as four doses in weeks 1, 2, 
9, and 10; n = 6–8 mice/group). For weight 
loss experiments, mice of each genotype and 
treatment group were placed on the HF diet 
for 12 weeks and then changed to the LF diet 
for 4 weeks to induce weight loss. 
For all experiments, body weights were 
quantified weekly at approximately 0900 
hours. At the study end point (approximately 
0600 hours), mice were transferred to the 
investigator’s laboratory using a stainless 
steel cart, and then anesthetized [ketamine/
xylazine, 10/100 mg/kg, by intraperitoneal 
(i.p.) injection beginning at approximately 
1100 hours] for exsanguination and tissue 
harvest [liver, subcutaneous adipose (SubQ), 
retro peritoneal adipose (RPF), epididymal 
adipose (EF), inter scapular brown adipose 
tissue (BAT), kidney, brain, and heart].
Measurement of body composition. Body 
composition of mice was determined by 
nuclear magnetic resonance spectroscopy 
[EchoMRI (magnetic resonance imaging)] at 
baseline (before diet adminis tration) and at 
study end point. Briefly, conscious mice were 
placed in clear, cylindrical plastic tubes (sized 
by animal weight) at approximately 1000 
hours. The tubes have holes for breathing 
and are maintained in a horizontal plane 
during the procedure. The scanner applies an 
external magnetic field at a level of 5-gauss 
beyond the surface of the system in a 9-in. 
radius from the edge of the animal holder. 
An equal field is present on the opposite side 
of the system. Three sequential scans (taking 
approximately 2 min each) were conducted 
for each animal. Following completion of 
the scan, the tubes were cleaned with soap 
and water using a long bottle brush. For this 
measurement, mice were transported using 
a stainless steel cart to a procedure room 
within the Division of Laboratory Animal 
Resources (DLAR) and then returned to 
the room where they were housed using 
the same cart.
Glucose (GTT) and insulin (ITT) toler-
ance tests. Mice were fasted for 4 or 6 hr for 
ITT or GTT, respectively, and blood glucose 
concentrations were measured using the tail 
vein with a handheld glucometer (Freedom 
Freestyle Lite; Abbott Laboratories). For the 
GTT, mice were transferred to a procedure 
room within the DLAR and injected i.p. with 
d-glucose (Sigma; 20% in saline, 10 μL/g of 
body weight at approximately 1300 hours); 
blood glucose concentrations were quanti-
fied at 0, 15, 30, 60, 90, and 120 min. For 
ITT, mice were transferred to a procedure 
room within DLAR, injected i.p. with human 
insulin [Novolin (Nordisk), 0.0125 μM in 
saline/g of body weight at approximately 1400 
hours], and blood glucose concentrations were 
quantified at 0, 30, 60, 90, and 120 min. 
Total area under the curve (AUC; arbitrary 
units) was calculated as previously described 
(Baker et al. 2013b).
Q u a n t i f i c a t i o n  o f  P C B - 7 7  a n d 
 hydroxylated metabolites in tissues. Tissue 
samples (EF, liver) were weighed and 
homogenized in distilled H2O (dH2O). 
Cold acetonitrile and 50 μL of internal 
standard (10 μM 13C-labeled d6-PCB-77) 
were added to homogenates, which were 
vortexed, sonicated, and centrifuged at 
15,000 rpm. Supernatants were transferred to 
glass vials, and pellets were reextracted with 
cold acetonitrile, with the process repeated 
twice. Pooled super natants were dried under 
nitrogen and reconstituted in 100 μL of 99/1 
methanol/dH2O containing 0.5% formic acid 
and 0.1% ammonium formate. PCB-77 and 
hydroxy-PCB-77 were measured using liquid 
chromatography-tandem mass spectrometry as 
described previously (Baker et al. 2013a). 
Extraction of RNA and quantification 
of mRNA abundance using real-time poly-
merase chain reaction (PCR). Total RNA was 
extracted from tissues (liver, adipose tissue, 
soleus muscle) using the SV Total RNA 
Isolation System kit (Promega Corporation) 
according to the manufacturer’s instructions. 
RNA concentrations were determined using a 
NanoDrop 2000 spectophotometer (Thermo 
Scientific). cDNA was synthesized from 0.4 μg 
total RNA with qScript cDNA SuperMix 
(Quanta Biosciences) in the following reaction: 
25°C for 5 min, 42°C for 30 min, and 
85°C for 5 min. The cDNA was diluted to 
0.4 ng/μL and amplified with an iCycler (Bio-
Rad) and Perfecta SYBR Green Fastmix for 
iQ (Quanta Biosciences). Using the difference 
from GAPDH rRNA (reference gene) and the 
comparative Ct method, the relative quantifi-
cation of gene expression in each sample was 
calculated. Primers (Eurofins MWG Operon) 
were designed using Primer-BLAST (http://
www.ncbi.nlm.nih.gov/tools/primer-blast/). 
The PCR reaction was as follows: 94°C for 
5 min, 40 cycles at 94°C for 15 sec, 58°C or 
64°C (based on tested primer efficiency) for 
40 sec, 72°C for 10 min, and 100 cycles from 
95°C to 45.5°C for 10 sec. Primer sequences 
were as follows: AhR, forward 5´-GACC 
AAAC ACAA GCTA GACT TCAC ACC, 
reverse 5´-CAAG AAGC CGGA AAAC TGTC 
ATGC; Cyp1A1, forward 5´-AGTC AATC 
TGAG CAAT GAGT TTGG -3´, reverse 
5´-GGCAT CCAG GGAA GAGT TAGG-3´; 
GAPDH, forward 5´-GCCA AAAG GGTC 
ATCA TCTC-3´, reverse 5´-GGCC ATCC 
ACAG TCTT CT-3´; Tnf‑alpha, forward 
5´-CCCA CTCT GACC CCTT TACT C-3´, 
reverse 5´-TCAC TGTC CCAG CATC 
TTGT-3; F4/80, forward 5´-CTTT GGCT 
ATGG GCTT CCAG TC-3´, reverse 5´- GCAA 
GGAG GACA GAGT TTAT CGTG-3´. 
Quantification of adipocyte size and cell 
number. Sections of formalin-fixed (10% 
wt/vol) pieces of SubQ tissue were stained 
with hematoxylin and eosin. Images of slides 
were taken at 10× magnification. Using 
the “detect edges” setting, image threshold, 
and object count features of NIS Elements 
software (Nikon Instruments Inc.), we quan-
tified the area of each adipocyte and the 
number of adipocytes within a 700 × 700 μm 
measurement frame. Adipocyte size was calcu-
lated on three measurement frames within 
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each section of adipose tissue per mouse from 
three mice per group. 
Differentiation of adipocytes from the 
stromal vascular fraction (SVF) of SubQ tissue. 
SubQ tissue was taken from the inguinal 
region, minced, and incubated in basal 
medium (Zenbio) supplemented with collage-
nase (1 mg/mL) and penicillin/streptomyocin 
(5%) for 1 hr with shaking at 37°C, as previ-
ously described (Rodbell 1964). Two days 
after SVF cells had reached 100% confluence, 
media was changed to differentiation medium 
(OM-DM; Zenbio) and changed every other 
day for 8 days. Cells were harvested for RNA 
using TRIzol (Life Technologies); cDNA 
synthesis and real-time PCR were performed 
as described above. The SVF was harvested 
at 100% confluence prior to addition of the 
adipocyte differentiation medium, and again 
at day 8 after differentiation (Adipo fraction).
Statistical analysis. Data are presented as 
mean ± SE. Data were log transformed prior 
to statistical analysis. A two-way analysis of 
variance (ANOVA; SigmaPlot, version 12.0; 
Systat Software Inc.) was used to determine 
statistical significance, which was defined as 
p < 0.05. GTT and ITT results were analyzed 
using repeated measure two-way ANOVA. 
The Holm-Sidak method was used for 
post hoc analyses.
Results
Generation and characterization of mice with 
adipocyte AhR deficiency. To confirm effec-
tive and specific deletion of exon 2 of AhR 
in adipocytes, we quantified AhR mRNA 
abundance in adipose tissues (SubQ, RPF, 
EF, BAT), liver, brain, heart, and kidney from 
mice fed standard laboratory diet (2 months 
of age). AhR mRNA abundances were not 
significantly different in liver, kidney, or 
brain from AhRfl/fl compared with AhRAdQ 
mice (Figure 1A). In the heart, AhR mRNA 
abundance was reduced in AhRAdQ compared 
with AhRfl/fl mice but did not meet criteria for 
statistical significance (Figure 1A; p = 0.17). In 
RPF white adipose tissue and BAT of AhRAdQ 
mice, AhR mRNA abundance was signifi-
cantly decreased compared with AhRfl/fl mice 
(Figure 1A; p < 0.05). Because adipose tissue 
is hetero geneous in cell types, preadipo cytes 
were differentiated from the SVF of SubQ 
tissue of mice from each genotype. AhR 
mRNA abundance was not significantly altered 
in preadipocytes from AhRAdQ mice prior to 
differentiation (SVF, Figure 1B). In contrast, 
AhR mRNA abundance was significantly 
reduced in fully differentiated adipocytes from 
AhRAdQ mice compared with AhRfl/fl controls 
(Adipo fraction, Figure 1B; p < 0.05).
Unexpectedly, 2-month-old male AhRAdQ 
mice fed standard mouse diet exhibited 
significantly increased fat mass and reduced 
lean mass compared with age-matched AhRfl/fl 
controls (Table 1). In addition, AhRAdQ mice 
had significantly larger visceral adipose depots 
(EF and RPF; p < 0.05) and moderately larger 
SubQ depots (p = 0.45; Table 1). However, 
these effects did not result in signifi cant 
differences in body weights between geno-
types (Table 1). Because differences in body 
fat deposition could potentially affect glucose 
homeo stasis, we conducted baseline GTTs 
and ITTs. There was no significant differ-
ence in glucose or insulin tolerance between 
genotypes in AhRAdQ mice compared with 
AhRfl/fl controls (see Supplemental Material, 
Figure S1A,B).
Effect of adipocyte AhR deficiency on 
insulin tolerance in lean mice acutely exposed 
to PCB-77. We previously demonstrated that 
lean mice exposed to four divided doses of 
PCB-77 develop impaired insulin tolerance 
within 48 hr after the last dose (Baker et al. 
2013b). Thus, we defined effects of adipocyte 
AhR deficiency on acute PCB-77–induced 
dys regulation of insulin tolerance in mice fed 
an LF diet (Figure 2A,B). Body weights were 
not significantly different between groups at 
the study end point (AhRfl/fl VEH, 28.1 ± 0.5; 
AhRfl/fl PCB-77, 27.9 ± 0.5; AhRAdQ VEH, 
25.5 ± 0.5; AhRAdQ PCB-77, 27.1 ± 0.5 g; 
p > 0.05). Compared with AhRfl/fl VEH 
mice, AhRAdQ VEH mice showed a modest, 
but significant, improvement in insulin 
tolerance, as indicated by a signifi cant reduc-
tion in blood glucose concentrations at 90 
and 120 min after insulin adminis tration 
Figure 1. Comparison of AhR-deficient mice (AhRAdQ) with AhRfl/fl controls. (A) AhR mRNA abundance in 
liver, kidney, brain, heart, retroperitoneal fat (RPF), and brown adipose tissue (BAT); data are mean ± SE 
from n = 5 mice/genotype. *p < 0.05 compared with AhRfl/fl. (B) AhR mRNA abundance in SVF (preadipo-
cytes) and after 8 days of differentiation to mature adipocytes (adipo fraction) in cells from AhRfl/fl and 
AhRAdQ mice fed standard mouse diet; data are mean ± SE from n = 3 mice/genotype. N.D., not detected. 
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Figure 2. Effect of adipocyte AhR deficiency on insulin tolerance in lean mice administered PCB-77. 
(A) Blood glucose concentrations following administration of insulin in mice of each genotype administered 
VEH or PCB-77 (week 3). Data are mean ± SE from n = 6–8 mice/group. *p < 0.05 compared with VEH within 
genotype. **p < 0.05 compared with AhRfl/fl within treatment. (B) Area under the curve (AUC) for data in (A). 
Data are mean ± SE from n = 6–8 mice/group. *p < 0.05 compared with AhRfl/fl within treatment. **p < 0.05 
compared with VEH within genotype. 
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Table 1. Characteristics of AhRfl/fl and AhRAdQ mice fed standard diet. 
Parameter/genotype AhRfl/fl AhRAdQ
Body weight (g) 24.6 ± 0.4 23.6 ± 0.5
Lean mass (% body weight) 81.0 ± 0.5 77.2 ± 1.2*
Fat mass (% body weight) 8.9 ± 0.3 11.2 ± 0.9*
Epididymal fat (EF) (g) 0.89 ± 0.12 1.27 ± 0.07*
Retroperitoneal fat (RPF) (g) 0.16 ± 0.02 0.26 ± 0.03*
Subcutaneous fat (SubQ) (g) 0.56 ± 0.08 0.74 ± 0.03
Data are mean ± SE from n = 6–8 mice/group.
*p < 0.05 compared with AhRfl/fl. 
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and by a significant reduction in the AUC 
(Figure 2A,B; p < 0.05). Notably, adminis-
tration of PCB-77 significantly impaired 
insulin tolerance in AhRfl/fl but not in AhRAdQ 
mice (Figure 2A,B; p < 0.05).
Effect of adipocyte AhR deficiency on the 
development of obesity, body fat distribution, 
and glucose homeostasis. Because obesity 
has been reported to increase the total body 
burden of lipophilic PCBs (Brown and 
Lawton 1984; Fukano and Doguchi 1977; 
McFarland and Clarke 1989), we examined 
effects of adipocyte AhR deficiency on the 
development of HF diet–induced obesity 
and glucose homeo stasis in mice of each 
genotype administered VEH or PCB-77. 
When challenged with an HF diet, adipo-
cyte AhR–deficient AhRAdQ mice adminis-
tered VEH had significantly increased body 
weights, reduced lean mass, and increased 
fat mass compared with AhRfl/fl controls 
(Figure 3A–C; p < 0.05). Moreover, excess 
adiposity in HF-fed AhRAdQ mice adminis-
tered VEH was deposited subcutaneously, 
with significant increases in SubQ tissue 
mass (AhRfl/fl, 3.8 ± 0.5; AhRAdQ, 5.5 ± 0.4; 
p < 0.05; representative images in Figure 3D) 
and adipocyte size compared with AhRfl/fl 
controls (Figure 4A,B). However, these effects 
were  not  observed  in  AhRAdQ  mice 
administered PCB-77 (Figure 4A). Moreover, 
in mice administered VEH, mRNA abun-
dance of F4/80, a macrophage marker, was 
significantly increased in EF tissue of AhRAdQ 
mice compared with AhRfl/fl controls, regard-
less of treatment group (VEH groups: AhRfl/fl, 
1.62 ± 0.67; AhRAdQ, 3.52 ± 0.68; p < 0.05; 
PCB-77 groups: AhRfl/fl, 1.29 ± 0.49; AhRAdQ, 
2.12 ± 0.68 ∆∆Ct; p < 0.05). In liver or 
soleus muscle from HF-fed mice adminis-
tered VEH, there was no significant effect 
of genotype on AhR mRNA abundance (see 
Supplemental Material, Figure S2; p = 0.06). 
However, adminis tration of PCB-77 resulted 
in a significant increase in AhR mRNA 
abundance in liver but not in soleus muscle 
from HF-fed mice of each genotype, with no 
significant differences between genotypes (see 
Supplemental Material, Figure S2; p < 0.05).
Consistent with previous findings (Baker 
et al. 2013b), PCB-77 had no significant 
effect on glucose tolerance in obese AhRfl/fl 
or AhRAdQ mice (see Supplemental Material, 
Figure S3A). At 12 weeks of HF feeding 
in PCB-77–treated mice of each genotype, 
adipose tissue concentrations of PCB-77 were 
considerably higher than those of its metabo-
lite hydroxy-PCB-77 (weight gain phase; 
see Supplemental Material, Figure S3B,C). 
Moreover, adipose concentrations of PCB-77 
were significantly higher in AhRAdQ mice 
compared with AhRfl/fl mice. In contrast, 
adipose concentrations of hydroxy-PCB-77 
were not significantly different between geno-
types (see Supplemental Material, Figure S3C).
Effect of adipocyte AhR deficiency on 
PCB-77–induced impairments of glucose and 
insulin tolerance in obese mice exhibiting 
weight loss. A previous study (Baker et al. 
2013b) demonstrated that when obese mice 
lost weight, benefits of weight loss to improve 
glucose and insulin tolerance were dimin-
ished in mice exposed to PCB-77 during the 
weight-gain phase of diet-induced obesity. 
Thus, obese AhRfl/fl and AhRAdQ mice adminis-
tered VEH or PCB-77 during the weight-
gain phase (12 weeks of HF feeding) were 
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made to lose weight by switching to an LF 
diet (4 weeks). Despite higher body weights of 
VEH-treated HF-fed AhRAdQ mice compared 
with VEH-treated AhRfl/fl controls prior to 
weight loss (Figure 3), after 4 weeks of the 
LF diet, there were no significant differences 
in body weights between the groups (see 
Supplemental Material, Figure S4).
As we demonstrated previously (Baker 
et al. 2013b), after weight loss AhRfl/fl 
PCB-77 mice exhibited significantly impaired 
glucose and insulin tolerance compared with 
AhRfl/fl VEH mice (Figure 5A–D; p < 0.05). 
In contrast, PCB-77 had no effect on glucose 
or insulin tolerance in AhRAdQ mice experi-
encing weight loss. In response to weight loss, 
concentrations of PCB-77 in adipose tissue 
decreased significantly in both genotypes (see 
Supplemental Material, Figure S3B; p < 0.05). 
Although concentrations of hydroxy-PCB-77 
increased in adipose tissue of both genotypes 
of mice after experiencing weight loss, levels 
of the PCB metabolite were significantly 
decreased in adipose tissue from AhRAdQ 
mice compared with AhRfl/fl controls (see 
Supplemental Material, Figure S3C; p < 0.05).
Previous studies demonstrated that 
adminis tration of PCB-77 during the weight-
gain phase of diet-induced obesity had no 
effect on adipose inflammation or glucose 
homeo stasis, presumably due to sequestration 
of the lipophilic toxicant in expanded adipose 
lipids (Baker et al. 2013b). However, when 
obese mice previously exposed to PCB-77 lost 
weight, the benefits of weight loss to reduce 
adipose mRNA abundance of TNF-α and 
to improve glucose tolerance were mitigated 
(Baker et al. 2013b). These results suggest 
that upon weight loss, PCB-77 is released 
from expanded adipose lipids of obese mice 
to promote AhR-mediated adipose inflamma-
tion and to impair glucose tolerance, blunting 
beneficial effects of weight loss. We quan-
tified mRNA abundance of AhR, CYP1A1 
(as a marker of AhR activation) and TNF-α 
(as a marker of inflammation) in adipose 
tissue of obese mice experiencing weight loss 
(mice were exposed to PCB-77 during the 
weight-gain phase of diet-induced obesity). 
In mice administered PCB-77, AhR mRNA 
abundance in adipose tissue was significantly 
decreased in AhRAdQ mice compared with 
AhRfl/fl mice (Figure 6A; p < 0.05). Similarly, 
in adipose tissue of AhRfl/fl mice adminis-
tered PCB-77, Cyp1A1 mRNA abundance 
was markedly increased, indicative of AhR 
activation (Figure 6B; p < 0.05). In contrast, 
PCB-77 had no effect on Cyp1A1 mRNA 
abundance in adipose tissue from mice with 
adipocyte AhR deficiency. Finally, Tnf-alpha 
mRNA abundance was significantly increased 
in adipose tissue of AhRfl/fl mice adminis-
tered PCB-77 compared with VEH, with no 
effect of the toxicant on Tnf-alpha mRNA 
abundance in adipose tissue of AhRAdQ mice 
(Figure 6C; p < 0.05). 
Discussion
Results from these experiments demonstrate 
a pivotal role for adipocyte AhRs in the 
regulation of adiposity and regional adipose 
deposition, and in the effects of lipophilic 
coplanar PCBs to impair glucose homeo stasis 
in mice. Because of their lipo philicity, PCBs 
bio accumu late in adipose lipids. Our results 
support the concept that adipose tissue is not 
simply an inert reservoir of these toxicants. 
Rather, bioaccumu la tion of PCBs within 
adipocyte lipids, with dynamic redistribu-
tion of PCBs upon lipolysis (e.g., with weight 
loss), results in activation of cyto plasmic AhR 
to impair glucose utilization and/or insulin 
signaling. Indeed, adipo cyte AhR deficiency 
totally abolished acute effects of coplanar 
PCBs to impair insulin tolerance in lean mice, 
and also abolished effects of PCBs to impair 
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glucose homeo stasis in obese mice experi-
encing weight loss. Moreover, we observed 
an unexpected pheno type of increased body 
weight and adiposity in HF-fed mice that 
lack AhR expression in adipocytes (AhRAdQ). 
Interestingly, with increased adiposity, 
AhRAdQ mice exhibited significant SubQ tissue 
deposition. Despite SubQ tissue deposition, 
overall increases in adiposity resulted in 
pronounced adipose inflammation and more 
significant impairments of glucose homeo stasis 
in HF-fed AhRAdQ mice. Because these effects 
were observed in HF-fed adipocyte AhR mice 
that were not exposed to environmental toxi-
cants, these results suggest that an endogenous 
ligand(s) of AhR plays a role in the regula-
tion of regional adiposity, adipose inflam-
mation, and glucose homeo stasis. Moreover, 
these results demonstrate that adipocyte AhRs 
mediate effects of coplanar PCBs to impair 
glucose homeo stasis in lean mice and in obese 
mice experiencing weight loss.
Previous studies in our laboratory demon-
strated that coplanar PCB ligands of the AhR 
promoted inflammation of mature murine 
3T3-L1 adipocytes (Arsenescu et al. 2008; 
Baker et al. 2013a, 2013b). Similarly, exog-
enous AhR ligands such as dioxin, as well 
as coplanar PCBs, promoted expression of 
a variety of inflammatory genes in human 
adipocytes (Kim et al. 2012). Moreover, 
administration of dioxin to C57BL/6 mice 
increased adipose tissue inflammation (Kim 
et al. 2012). Results from the present study 
demonstrate that deficiency of adipocyte AhR 
promotes adipose inflammation, including 
infiltration of macrophages into adipose tissue 
(as detected by F4/80 expression). Moreover, 
these results extend previous findings by 
demonstrating that a coplanar PCB acts at 
adipocyte AhR to increase expression of the 
proinflammatory cytokine TNF-α in adipose 
tissue as well as to impair insulin resistance 
in C57BL/6 mice. Notably, acute effects of 
PCB-77 to impair glucose homeo stasis in lean 
mice, and in obese mice experiencing weight 
loss, were abolished in mice with adipocyte 
AhR deficiency. These results demonstrate 
that PCB-induced alterations in glucose 
homeo stasis are mediated through adipocyte 
AhR. Selective effects of lipophilic toxicants 
such as PCBs at adipocyte AhR may relate to 
their marked bioaccumul a tion within adipose 
lipids (Bourez et al. 2012, 2013).
An unexpected finding of the present study 
was an increase in body weight, adiposity, and 
impaired glucose homeo stasis in AhRAdQ mice 
fed an HF diet (i.e., the VEH group). Anorexia 
and/or body wasting have been described 
as toxic manifestations of dioxin exposure 
(Tuomisto et al. 1995). In addition, dioxin has 
been demonstrated to reduce differentiation 
of 3T3-L1 adipocytes in an AhR-dependent 
manner (Alexander et al. 1998). However, 
effects of AhR activation appear to be concen-
tration dependent, as previous studies in our 
laboratory demonstrated that low concentra-
tions (< 0.1 nM) of dioxin, as well as coplanar 
PCBs (3.4 μM), promote differentiation of 
3T3-L1 adipocytes, whereas higher concen-
trations of these AhR ligands (10 nM dioxin 
and 34 μM coplanar PCBs) inhibited adipo-
cyte differentiation (Arsenescu et al. 2008). In 
addition to regulation of adipocyte differen-
tiation, mouse embryonic fibro blasts (either as 
preadipocytes or differentiated to adipocytes) 
from mice with whole-body AhR deficiency 
exhibited elevated triglyceride synthesis 
(Alexander et al. 1998). Results from the 
present study demonstrate that, in the setting 
of diet-induced obesity, deficiency of adipo-
cyte AhR results in increased adipocyte size 
and adiposity. It is unclear if adipocyte AhR 
deficiency stimulated differen tia tion of new 
adipocytes (Arsenescu et al. 2008) or enhanced 
triglyceride synthesis to promote adiposity. 
Moreover, AhR-mediated regulation of body 
weight may result from the combined effects of 
activation of AhR in various cell types because 
congenic mice with high AhR signaling activity 
were more susceptible to diet-induced obesity 
compared with those with low AhR activity 
(Kerley-Hamilton et al. 2012). Further studies 
are warranted to define cell-specific mecha-
nisms for AhR regulation of adipose mass and 
body weight.
In addition to an increase in overall 
adiposity and body weight when challenged 
with an HF diet, adipocyte AhR–deficient 
male mice (AhRAdQ) exhibited enhanced 
deposition of SubQ tissue. Overall increases 
in adiposity of obese adipocyte AhR–deficient 
mice resulted in more pronounced impair-
ments of glucose homeo stasis. Estrogen has 
been associated with a gynoid lower body 
distribution of adipose tissue (subcutaneously) 
in females, whereas androgen may contribute 
to more upper body (visceral) adipose deposi-
tion in males. The AhR interacts with estrogen 
and its receptors through various mechanisms, 
including potential estrogenic effects in the 
absence of estrogen, versus anti estrogenic 
effects in the presence of estrogen (Brunnberg 
et al. 2011). It is possible that alterations 
in adipose deposition in HF-fed adipocyte 
AhR–deficient mice may result from either an 
estrogenic or anti androgenic effect to promote 
gynoid adipose deposition. Further studies 
are required to define the basis of changes in 
regional adiposity in adipocyte AhR–deficient 
mice fed an HF diet.
Coplanar PCBs are substrates for Cyp1A1, 
a target gene of AhR activation, resulting in 
the production of water-soluble hydroxylated 
metabolites that are more readily excreted 
(Toborek et al. 1995). Results from the 
present study demonstrate that during the 
weight gain phase of diet-induced obesity, 
PCB-77 is not readily metabolized to 
hydroxy metabolites in adipocytes. This is 
most likely the result of sequestration of the 
parent toxicant to adipocyte triacyl glycerol 
droplets, where CYP1A1 does not have ready 
access to the substrate. Similar to previous 
reports (Kim et al. 2011), levels of PCB-77 
in adipose tissue were increased in adipocyte 
AhR–deficient mice exhibiting increased body 
weight and adiposity. It is possible that eleva-
tions in adipose levels of the parent toxicant, 
PCB-77, contributed to an ability of the 
toxicant to act at other target sites important 
in the control of body weight, adipose mass, 
and the regulation of glucose homeo stasis. 
For example, in the present study, adipocyte 
AhR–deficient mice exposed to PCB-77 
did not exhibit increased adiposity or body 
weight, suggesting that increased levels of the 
parent toxicant acted at AhR on other cell 
types to protect against obesity and impair 
glucose homeo stasis. In support, exposure 
of C57BL/6 mice fed a very high-fat diet to 
persistent organic pollutants that included 
AhR ligands resulted in paradoxical improve-
ments in insulin and glucose tolerance 
(Ibrahim et al. 2011). As previously indicated 
(Ibrahim et al. 2011) the interplay between 
dietary nutrients and environmental pollut-
ants is complex; however, our results suggest 
that actions of PCBs at adipocyte AhR 
mediate harmful effects of the toxicant to 
impair glucose homeo stasis.
In the present study, upon weight loss in 
AhRfl/fl mice, levels of the hydroxy-PCB-77 
metabolite in adipose tissue increased markedly 
and were associated with a marked induc-
tion of adipose CYP1A1. In contrast, adipose 
tissue from AhRAdQ mice experiencing weight 
loss did not exhibit increased abundance of 
CYP1A1, which most likely contributed to 
reduced adipose levels of the hydroxy-PCB-77 
metabolite. These results demonstrate that 
CYP1A1 induction by PCB-77 in adipose 
tissue, mediated by adipocyte AhR, are associ-
ated with increased levels of hydroxy-PCB-77.
Conclusions
Results from this study demonstrate that 
coplanar PCBs act at adipocyte AhR to 
promote adipose inflammation and impair 
glucose homeo stasis in lean mice and in obese 
mice experiencing weight loss. Moreover, 
results demonstrate a previously unappreciated 
role for adipocyte AhR to regulate adiposity, 
adipose inflammation, body weight, and 
glucose homeo stasis in mice with diet-induced 
obesity. These results suggest that bioaccumu-
lation of lipophilic coplanar PCBs to adipose 
tissue contributes to the development of 
adipocyte insulin resistance. Moreover, endog-
enous AhR ligands, present in the setting of 
diet-induced obesity, may play a pivotal role 
in regulating adipose mass and deposition.
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